| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $3.27 | $2.82 | $3.15 | $2.87 | $0.53 | $0.44 | $0.51 | $0.40 |
| EPS (Diluted) | $3.25 | $2.82 | $3.15 | $2.86 | $0.52 | $0.44 | $0.50 | $0.39 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.7B | $2.6B | $2.4B | $2.4B | $1.9B | $1.4B | $0.7B | $0.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B |
| Total Liabilities | $2.5B | $2.4B | $2.2B | $2.1B | $1.7B | $1.2B | $0.6B | $0.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Investing Cash Flow | $-0.1B | $-0.2B | $-0.1B | $-0.5B | $-0.3B | $0.0B | $-0.0B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.1B | $0.1B | $0.1B | $0.4B | $0.3B | $-0.0B | $0.0B | $0.0B |